Tolerability and efficacy of parenteral iron therapy in hemodialysis patients, a comparison of preparations
- 13 March 2007
- journal article
- Published by Wiley in Transfusion Alternatives in Transfusion Medicine
- Vol. 9 (1), 37-42
- https://doi.org/10.1111/j.1778-428x.2007.00050.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Parenteral iron therapy optionsAmerican Journal of Hematology, 2004
- AnemiaArchives of Internal Medicine, 2003
- PRE-dialysis survey on anaemia managementNephrology Dialysis Transplantation, 2003
- Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patientsKidney International, 2003
- Total Dose Intravenous Infusion of Iron Dextran for Iron-Deficiency Anemia in Children With Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2002
- Suspected iron dextran-related adverse drug events in hemodialysis patientsAmerican Journal of Kidney Diseases, 2001
- Adverse Events in Chronic Hemodialysis Patients Receiving Intravenous Iron Dextran – A Comparison of Two ProductsAmerican Journal of Nephrology, 2000
- Intravenous iron for the treatment of predialysis anemiaKidney International, 1999
- Effective utilization of erythropoietin with intravenous iron therapyJournal of Clinical Pharmacy & Therapeutics, 1998
- Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapyAmerican Journal of Kidney Diseases, 1997